Lapix Therapeutics Inc.
Clinical trials sponsored by Lapix Therapeutics Inc., explained in plain language.
-
New pill for itchy skin conditions enters early human testing
Symptom relief Recruiting nowThis early-stage study tests the safety of an experimental oral drug, LPX-TI641, in 48 adults with atopic dermatitis (eczema) or psoriasis. Participants take the drug or a placebo daily for 28 days. The main goal is to check for side effects and how the drug moves through the bod…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Symptom relief
Last updated May 26, 2026 06:53 UTC
-
New arthritis drug enters early safety testing
Symptom relief Recruiting nowThis early-stage study tests a new oral drug, LPX-TI641, in 48 adults with rheumatoid arthritis or psoriatic arthritis. The main goal is to see if the drug is safe and tolerable compared to a placebo over 28 days. Researchers will also measure how the drug moves through the body.…
Phase: PHASE1 • Sponsor: LAPIX Therapeutics Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:00 UTC